Incyte (INCY) Capital Expenditures (2010 - 2026)
Incyte posted quarterly Capital Expenditures of $10.2 million for Q1 2026, up 221.87% year-on-year from $3.2 million in Q1 2025, and down 81.36% on a QoQ basis from $54.7 million in Q4 2025.
Incyte (INCY) has 17 years of Capital Expenditures data on file, last reported at $10.2 million in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures rose 221.87% year-over-year to $10.2 million; the trailing twelve-month figure through Mar 2026 stood at $65.9 million (up 1124.19% YoY), and the FY2025 full-year result was $58.9 million, up 2166.73% from the prior year.
- Capital Expenditures for Q1 2026 stood at $10.2 million, down from $54.7 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $54.7 million in Q4 2025 and bottomed at -$53.1 million in Q4 2022.
- The 5-year median for Capital Expenditures is $3.2 million (2025), against an average of $6.3 million.
- The widest annual swing landed in 2023, when Capital Expenditures plunged 169.15%; it then surged 5913.92% in 2025.
- A 5-year view of Capital Expenditures shows it stood at -$53.1 million in 2022, then soared by 161.2% to $32.5 million in 2023, then slumped by 102.9% to -$941000.0 in 2024, then soared by 5913.92% to $54.7 million in 2025, then slumped by 81.36% to $10.2 million in 2026.
- The last three Capital Expenditures figures came in at $10.2 million (Q1 2026), $54.7 million (Q4 2025), and $112000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn | 10.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.20 Mn |
| Mar 31, 2026 | 10.20 Mn |
| Dec 31, 2025 | 54.71 Mn |
| Dec 31, 2025 | 54.71 Mn |
| Sep 30, 2025 | 112,000.00 |
| Sep 30, 2025 | 112,000.00 |
| Jun 30, 2025 | 877,000.00 |
| Jun 30, 2025 | 877,000.00 |
| Mar 31, 2025 | 3.17 Mn |
| Mar 31, 2025 | 3.17 Mn |
| Dec 31, 2024 | -941,000.00 |
| Dec 31, 2024 | -941,000.00 |
| Sep 30, 2024 | 2.74 Mn |
| Sep 30, 2024 | 2.74 Mn |
| Jun 30, 2024 | 417,000.00 |
| Jun 30, 2024 | 417,000.00 |
| Mar 31, 2024 | 383,000.00 |
| Mar 31, 2024 | 383,000.00 |
| Dec 31, 2023 | 32.48 Mn |
| Dec 31, 2023 | 32.48 Mn |
| Sep 30, 2023 | -19.23 Mn |
| Sep 30, 2023 | -19.23 Mn |
| Jun 30, 2023 | 7.34 Mn |
| Jun 30, 2023 | 7.34 Mn |
| Mar 31, 2023 | 11.91 Mn |
| Mar 31, 2023 | 11.91 Mn |
| Dec 31, 2022 | -53.07 Mn |
| Dec 31, 2022 | -53.07 Mn |
| Sep 30, 2022 | 27.81 Mn |
| Sep 30, 2022 | 27.81 Mn |
| Jun 30, 2022 | 12.99 Mn |
| Jun 30, 2022 | 12.99 Mn |
| Mar 31, 2022 | 15.76 Mn |
| Mar 31, 2022 | 15.76 Mn |
| Dec 31, 2021 | -119.45 Mn |
| Dec 31, 2021 | -119.45 Mn |
| Sep 30, 2021 | 32.15 Mn |
| Sep 30, 2021 | 32.15 Mn |
| Jun 30, 2021 | 93.13 Mn |
| Jun 30, 2021 | 93.13 Mn |
| Mar 31, 2021 | 21.26 Mn |
| Mar 31, 2021 | 21.26 Mn |
| Dec 31, 2020 | 9.97 Mn |
| Dec 31, 2020 | 9.97 Mn |
| Sep 30, 2020 | -1.98 Mn |
| Sep 30, 2020 | -1.98 Mn |
| Jun 30, 2020 | -24.45 Mn |
| Jun 30, 2020 | -24.45 Mn |
| Mar 31, 2020 | 39.27 Mn |
| Mar 31, 2020 | 39.27 Mn |
| Dec 31, 2019 | -36.02 Mn |
| Dec 31, 2019 | -36.02 Mn |
| Sep 30, 2019 | -16.81 Mn |
| Sep 30, 2019 | -16.81 Mn |
| Jun 30, 2019 | 47.29 Mn |
| Jun 30, 2019 | 47.29 Mn |
| Mar 31, 2019 | 18.27 Mn |
| Mar 31, 2019 | 18.27 Mn |
| Dec 31, 2018 | -40.53 Mn |
| Dec 31, 2018 | -40.53 Mn |
| Sep 30, 2018 | 24.82 Mn |
| Sep 30, 2018 | 24.82 Mn |
| Jun 30, 2018 | 10.79 Mn |
| Jun 30, 2018 | 10.79 Mn |
| Mar 31, 2018 | 12.59 Mn |
| Mar 31, 2018 | 12.59 Mn |
| Dec 31, 2017 | 100.25 Mn |
| Dec 31, 2017 | 100.25 Mn |
| Sep 30, 2017 | -40.69 Mn |
| Sep 30, 2017 | -40.69 Mn |
| Jun 30, 2017 | 30.50 Mn |
| Jun 30, 2017 | 30.50 Mn |
| Mar 31, 2017 | 20.97 Mn |
| Mar 31, 2017 | 20.97 Mn |
| Dec 31, 2016 | 4.00 Mn |
| Dec 31, 2016 | 4.00 Mn |
| Sep 30, 2016 | -80.79 Mn |
| Sep 30, 2016 | -80.79 Mn |
| Jun 30, 2016 | 82.21 Mn |
| Jun 30, 2016 | 82.21 Mn |
| Mar 31, 2016 | 5.56 Mn |
| Mar 31, 2016 | 5.56 Mn |
| Dec 31, 2015 | 6.90 Mn |
| Dec 31, 2015 | 6.90 Mn |
| Sep 30, 2015 | 13.36 Mn |
| Sep 30, 2015 | 13.36 Mn |
| Jun 30, 2015 | 2.20 Mn |
| Jun 30, 2015 | 2.20 Mn |
| Mar 31, 2015 | 3.55 Mn |
| Mar 31, 2015 | 3.55 Mn |
| Dec 31, 2014 | 1.06 Mn |
| Dec 31, 2014 | 1.06 Mn |
| Sep 30, 2014 | 15.45 Mn |
| Sep 30, 2014 | 15.45 Mn |
| Jun 30, 2014 | 8.70 Mn |
| Jun 30, 2014 | 8.70 Mn |
| Mar 31, 2014 | 2.66 Mn |
| Mar 31, 2014 | 2.66 Mn |
| Dec 31, 2013 | 17.04 Mn |
| Dec 31, 2013 | 17.04 Mn |
| Sep 30, 2013 | 789,000.00 |
| Sep 30, 2013 | 789,000.00 |
| Jun 30, 2013 | 553,000.00 |
| Jun 30, 2013 | 553,000.00 |
| Mar 31, 2013 | 894,000.00 |
| Mar 31, 2013 | 894,000.00 |
| Dec 31, 2012 | 930,000.00 |
| Dec 31, 2012 | 930,000.00 |
| Sep 30, 2012 | 406,000.00 |
| Sep 30, 2012 | 406,000.00 |
| Jun 30, 2012 | 1.01 Mn |
| Jun 30, 2012 | 1.01 Mn |
| Mar 31, 2012 | 496,000.00 |
| Mar 31, 2012 | 496,000.00 |
| Dec 31, 2011 | 992,000.00 |
| Dec 31, 2011 | 992,000.00 |
| Sep 30, 2011 | 1.18 Mn |
| Sep 30, 2011 | 1.18 Mn |
| Jun 30, 2011 | 1.08 Mn |
| Jun 30, 2011 | 1.08 Mn |
| Mar 31, 2011 | 552,000.00 |
| Mar 31, 2011 | 552,000.00 |
| Dec 31, 2010 | 2.74 Mn |
| Dec 31, 2010 | 2.74 Mn |
| Sep 30, 2010 | 466,000.00 |
| Sep 30, 2010 | 466,000.00 |
| Jun 30, 2010 | 598,000.00 |
| Jun 30, 2010 | 598,000.00 |
| Mar 31, 2010 | 306,000.00 |
| Mar 31, 2010 | 306,000.00 |